Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem … – GlobeNewswire (press release)
|
Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem …
GlobeNewswire (press release) ATLANTA, Dec. 09, 2017 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced results from a leading … |
